ALCAR Prophylaxis Study

NCT00225160 is an interventional clinical trial that is for HIV Infections, and Distal Symmetric Polyneuropathy conditions and was started in November of 2003. This trial has 50 people enrolled who are within the adult and senior age range. This trial is funded by an industry organization, and an outside organization. The specific sponsors / contributors of this trial are as follows: Royal Free Hampstead NHS Trust, Bristol-Myers Squibb, and Sigma-Tau Research, Inc.. The following interventions were used in this trial: (drug) acetyl L-carnitine.